California Nanotechnologies Corp.
CANOF
$0.45
$0.01353.09%
OTC PK
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Revenue | 16.73% | 55.81% | 121.93% | 243.37% | 171.25% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.73% | 55.81% | 121.93% | 243.37% | 171.25% |
| Cost of Revenue | 41.11% | 10.04% | 82.88% | 163.13% | 270.81% |
| Gross Profit | 8.39% | 78.18% | 132.50% | 308.31% | 148.58% |
| SG&A Expenses | 45.39% | 50.22% | 108.59% | 145.77% | 178.40% |
| Depreciation & Amortization | 421.64% | 320.27% | 228.30% | 219.06% | -1.08% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 58.29% | 43.90% | 109.91% | 160.71% | 177.31% |
| Operating Income | -23,982.35% | 86.03% | 144.09% | 811.44% | -80.00% |
| Income Before Tax | 62.22% | -77.96% | -404.99% | 1,817.36% | -6,725.00% |
| Income Tax Expenses | 18,777.78% | -- | 0.00% | -- | -128.13% |
| Earnings from Continuing Operations | 18.07% | -77.99% | -406.50% | 1,860.56% | -4,234.09% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 18.07% | -77.99% | -406.50% | 1,860.56% | -4,234.09% |
| EBIT | -23,982.35% | 86.03% | 144.09% | 811.44% | -80.00% |
| EBITDA | -1,433.47% | 85.78% | 118.07% | 675.00% | -36.98% |
| EPS Basic | 25.27% | -83.97% | -319.40% | 1,327.27% | -2,933.33% |
| Normalized Basic EPS | 64.91% | -83.51% | -323.81% | 1,300.00% | -5,600.00% |
| EPS Diluted | 25.27% | -78.00% | -333.33% | 809.09% | -2,933.33% |
| Normalized Diluted EPS | 64.91% | -84.62% | -302.50% | 1,200.00% | -5,600.00% |
| Average Basic Shares Outstanding | 9.01% | 36.16% | 39.47% | 38.99% | 31.93% |
| Average Diluted Shares Outstanding | 9.01% | 46.07% | 53.49% | 42.29% | 31.93% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |